Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

November 29, 2012: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Agenda

Food and Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee
Meeting #56
November 29, 2012
National Institutes of Health, Building 29A, Conference Room 1A09


Open Session: Overview of Research Programs in the Center for Biologics Evaluation and Research (CBER); the Office of Cellular Tissue and Gene Therapies (OCTGT); the Division of Cellular and Gene Therapies (DCGT) and Summary of Individual Research Programs in the Gene Transfer and Immunogenicity Branch (GTIB)

1:00 p.m.  (EST)Call to Order

Roll Call
Conflict of Interest Statement
Evan Snyder, M.D., Ph.D., Chair

Gail Dapolito
Designated Federal Officer
1:10Overview CBER Research Programs
Overview OCTGT Research Programs
Carolyn Wilson, Ph.D.
Associate Director for Research, CBER
1:30Overview DCGT Research ProgramsRaj Puri, M.D., Ph.D., Director, DCGT
1:40 Q&A 
1:45Summary GTIB Research ProgramsAndrew Byrnes, Ph.D., Chief, GTIB
2:20Open Public Hearing 
3:20 Closed Session 
4:30 p.m.Adjourn 

Page Last Updated: 10/13/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English